Regulation of the functional interaction between cyclin D1 and the estrogen receptor

Molecular and Cellular Biology

Volumn 20, Issue 23, 2000, Pages 8667-8675

  Lamb, J ^a   Ladha, M H ^a   McMahon, C ^a   Sutherland, R L ^a   Ewen, M E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; ESTROGEN RECEPTOR;

ARTICLE; BREAST EPITHELIUM; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYBRID; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADIPOCYTES; ANIMALS; BREAST; BREAST NEOPLASMS; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIN D1; EPITHELIAL CELLS; ESTRADIOL; HUMANS; LIGANDS; MICE; PROTEIN BINDING; RATS; RECEPTORS, ESTROGEN; STROMAL CELLS;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS; MURINAE;

EID: 0034458854     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.23.8667-8675.2000     Document Type: Article

References (82)

1. Cytodifferentiation of mouse mammary epithelial cells cultured on reconstituted basement membrane reveals striking similarities to development in vivo
2. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
3. Mammary epithelial reorganization on extracellular matrix is mediated by cell surface galactosyltransferase
4. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane
5. Cyclin D1 protein expression and function in human breast cancer
6. CDK-independent activities of D type cyclins
7. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phonotype and poor prognosis
8. Expression and amplification of cyclin genes in human breast cancer
9. Phosphorylation of human estrogen receptor a by protein kinase A regulates dimerization
10. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
11. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells
12. Intracellular cAMP levels in normal rat mammary gland and adenocarcinoma. In vivo vs. in vitro
13. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors
14. Postnatal development of the rodent mammary gland
15. Control of the three-dimensional growth pattern of mammary epithelium: Role of genes of the Wnt and erbB families studied using recombinant epithelium
16. Interaction between estradiol and cAMP in the regulation of specific gene expression
17. p53-dependent repression of CDK4 translation in TGF-β-induced G1 cell cycle arrest
18. Perturbation of β-integrin function alters the development of murine mammary gland
19. Modulation of adhesion-dependent cAMP signaling by echistatin and alendronate
20. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
21. Cyclic AMP-dependent protein kinase in rat mammary tissue: Expression of catalytic and regulatory subunits throughout pregnancy and lactation
22. Rescue of cyclin D1 deficiency by knockin cyclin E
23. Amplification and overexpression of cyclin D1 in breast cancer detected by immunocytochemical staining
24. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperlasia
25. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue
26. Sublines of mouse 3T3 cells that accumulate lipid
27. Adenosine 3′,5′-cyclic monophosphate and guanosine 3′,5′-cyclic monophosphate levels in human breast cancer tissue
28. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer
29. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis
30. Mammary gland morphogenesis is inhibited in transgenic mice that overexpress cell surface beta1,4-galactosyl-transferase
31. Think globally, act locally: The making of a mouse mammary gland
32. Int-2 amplification in breast cancer: Association with decreased survival and relationship to amplification of c-erbB-2 and c-myc
33. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent kinase-independent mechanism
34. Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development
35. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: Correlation with tumour proliferation and oestrogen receptor status
36. Functional domains of the human estrogen receptor
37. Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue
38. New functional activities for the p21 family of CDK inhibitors
39. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
40. Cell-cell interactions promote mammary epithelial cell differentiation
41. Cyclic AMP changes in guinea pig mammary gland and milk
42. Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B
43. Protein kinase activity in mouse mammary carcinoma
44. D-type cyclin-dependent kinase activity in mammalian cells
45. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
46. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
47. 1 kinase activity for cdk6, a novel cyclin D partner
48. A clinopathological study on overexpression of cyclin D1 and p53 in a series of 248 patients with operable breast cancer
49. Cyclic AMP binding proteins and prognosis in breast cancer
50. Tumour cyclic AMP binding proteins: An independent prognostic factor for disease recurrence and survival in breast cancer
51. Elevated cyclic AMP levels in human breast-cancer tissue
52. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4
53. Identification of a third autonomous activation domain within the human estrogen receptor
54. Release of cAMP gating by the α6β4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells
55. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast
56. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
57. C-myc or cyclin D1 mimics estrogen effects on cyclin E-cdk2 activation and cell cycle reentry
58. Cyclic nucleotides, adenylate cyclase and cyclic AMP phosphodiesterase in mammary glands from pregnant and lactating mice
59. New aspects of stroma-parenchyma relations in mammary gland differentiation
60. Changes in the activities of adenylate cyclase and cAMP phosphodiesterase and the level of 3′,5′-cyclic adenosine monophosphate in rat mammary gland during pregnancy and lactation
61. The role of cyclic nucleotides in the development and function of rat mammary tissue
62. Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype
63. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer
64. Protein kinase A phosphorylates cyclin D1 at three distinct sites within the cyclin box and at the C-terminus
65. Protein kinase activity in the rat mammary gland during pregnancy, lactation, and weaning: A correlation with growth but not with progesterone receptor levels
66. Cholera toxin treatment increases in vivo growth and development of mouse mammary gland
67. Mammalian G1 cyclins
68. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
69. In vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts
70. Electron-microscopic cytochemical localization of adenylate cyclase activity in the myoepithelial cells of the lactating mouse mammary gland
71. Mammalian p50cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes cdk4
72. The stromal proteinase MMP3/Stromelysin-1 promotes mammary carcinogenesis
73. Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
74. Laminin mediates tissue-specific gene expression in mammary epithelia
75. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells
76. Distinct roles for cyclin-dependent kinases in cell cycle control
77. Reversion of the malignant phenotype of human breast cancer cells in three-dimensional culture and in vivo by integrin blocking antibodies
78. The retinoblastoma protein and cell cycle control
79. Overexpression of cyclin D1 mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions
80. Milk protein expression and ductal morphogenesis in the mammary gland in vitro: Hormone-dependent and -independent phases of adipocyte-mammary epithelial cell interaction
81. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
82. CDK-independent activation of estrogen receptor by cyclin D1